查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
家庭診斷檢驗市場與趨勢(COVID-19，FOB，葡萄糖，HIV，其他檢驗):2023年
市場調查報告書
商品編碼
1287796

家庭診斷檢驗市場與趨勢(COVID-19，FOB，葡萄糖，HIV，其他檢驗):2023年

At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023
出版日期: | 出版商: Kalorama Information | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

本報告提供家庭診斷檢驗市場相關調查，家庭檢驗的概要，各市場區隔趨勢，市場參與企業，及競爭分析等彙整資訊。

目錄

第1章 摘要整理

第2章 簡介

  • 概要
  • 課題和趨勢
  • COVID-19
  • 家庭檢驗的保險
  • 家庭IVD檢驗的推動因素與課題
  • 遺傳學
  • 家庭檢體採取

第3章 家庭IVD檢驗

  • 簡介
  • 糖尿病
  • 妊娠、不孕
  • 感染疾病
  • HIV
  • COVID-19
  • COVID-19和流感
  • 凝固
  • 糞便潛血
  • 膽固醇
  • 濫用藥物
  • 家庭IVD檢驗市場，各檢驗類型
  • 家庭IVD檢驗市場，各樣本類型
  • 血液樣本
  • 尿液樣本
  • 口腔/唾液樣本
  • 鼻子樣本
  • 糞便樣本
  • 其他

第4章 家庭檢體採取IVD檢驗

  • 簡介
  • 妊娠和生殖能力
  • 感染疾病
  • HIV
  • HPV以及其他的性感染疾病
  • COVID-19
  • COVID-19和流感
  • 糞便潛血
  • 膽固醇
  • 遺傳學
  • 家庭檢體採取IVD檢驗，各檢驗類型
  • 隱私
  • 家庭檢體採取IVD檢驗，各樣本類型
  • 血液樣本
  • 尿液樣本
  • 口腔/唾液樣本
  • 鼻子樣本
  • 糞便樣本
  • 其他

第5章 市場參與企業

  • 23andMe, Inc.
  • Abbott Diagnostics
  • AccessBio, Inc
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Atomo Diagnostics
  • Becton-Dickinson
  • binx health
  • Biomerica, Inc
  • Biosynex SA
  • BTNX Inc.
  • Church & Dwight Co. Inc.
  • Color Health, Inc.
  • Cue Health
  • Dexcom, Inc.
  • EasyDNA
  • Everlywell
  • Exact Sciences
  • First Check Diagnostics LLC
  • GlysBy diagnostics
  • Helena Laboratories
  • Hemosure, Inc.
  • LifeScan, Inc.
  • Medichecks.com Ltd
  • Myriad Genetics, Inc.
  • OraSure Technologies, Inc.
  • Polymedco, Inc.
  • Preventis GmbH
  • Prima Lab SA
  • QuidelOrtho Corporation
  • Roche Diagnostic Corporation
  • Siemens Healthineers GmbH
  • Swiss Precision Diagnostics GmbH
  • Trividia Health
  • VedaLab

第6章 市場分析

  • 市場概要
  • 各檢驗類型市場區隔
  • 葡萄糖和HbA1c
  • 感染疾病
  • 其他的領域
  • 遺傳性
  • 各流通管道市場
  • 各地區市場
  • 競爭分析
簡介目錄
Product Code: 23-720c

This new Kalorama Information report, “At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023”, examines a range of both at-home tests and home collection tests. The At-Home in vitro diagnostic (IVD) testing market is comprised of IVD tests that can be purchased at the local store or on the Internet where the patient gathers the specimen and results are displayed usually within minutes. Generally, these are lateral flow technology or dip stick methods.

Meanwhile, the global Home IVD testing market is a growing market with much potential. The Home Collection IVD testing market is comprised of testing kits that are obtained from the local pharmacy or internet and sent to the patient's home. The patient collects the specimen, puts it into a collection container and sends it to the laboratory for testing. Results are sent back to the patient and/or referring physician.

This report covers the At-Home and Home testing markets by segmenting them into several broad areas including:

  • Cholesterol
  • Drugs of Abuse
  • Fecal Occult Blood
  • Glucose/ HbA1c including CGM
  • Infectious Disease
    • COVID-19 / + Flu + RSV
    • HIV
  • Pregnancy and Fertility
  • Rapid Coagulation
  • Genetic (excluding ancestry genetic testing)

The base year for data featured in the report is 2022. Data are provided for 2022 and 2027 with compound annual growth rates (CAGRs) for 2022 and 2027. Competitive analysis is provided for the top five participants in the market. Regional breakdowns are surveyed for United States, EMEA, Asia-Pacific and Rest of World for 2019-2022. The forecasted market analysis for 2022-2027 was largely based on demographic trends, new developments, innovative technology and global expansion.

Table of Contents

Chapter 1: Executive Summary

  • Industry at a Glance
  • Scope and Methodology
  • Size and Growth of the Market
    • Figure 1-1: Global Home IVD Market, by Key Segment (Glucose/HbA1c, COVID-19, Other, Genetic), 2019-2022
  • Key Issues and Trends Affecting the Market
  • Competitive Outlook
  • Conclusion Highlights

Chapter 2: Introduction

  • Overview
  • Issues and Trends
  • COVID-19
    • Figure 2-1: Home COVID-19 Test Distribution of Sales by Vendor (Abbott Diagnostics, Becton Dickinson, OraSure Technologies, Siemens Healthineers, Quidel, Others)
  • Insurance for Home Tests
    • Figure 2-2: Diabetes State Mandates - State-Level Insurance Mandates for Benefits, ACA Marketplace Coverage
  • Home IVD Testing Drivers and Challenges
    • Figure 2-3: Benefits to Home Testing vs. Challenges in Home Testing
  • Genetics
    • Table 2-1: Home Genetic Laboratory Testing, Market Drivers and Barriers
  • Home Collection

Chapter 3: At-Home IVD Tests

  • Introduction
  • Diabetes
    • Table 3-1: Selected Glucose At-Home Testing Meter Innovations
  • Pregnancy and Fertility
  • Infectious Disease
  • HIV
  • COVID-19
  • COVID-19 & Flu
    • Table 3-2: Selected COVID- 19 and COVID-19 & Flu A/B At-Home Tests for SARS-CoV-2
  • Coagulation
  • Fecal Occult Blood
  • Cholesterol
  • Drugs of Abuse
  • At-Home IVD Test Market by Test Type
    • Table 3-3: Global At-Home IVD Market by Test Type (Glucose, Infectious Disease, Other), 2022 ($BN)
    • Figure 3-1: Global At-Home IVD Market by Distribution of Sales by Segment (Glucose, COVID-19+, HIV, Other Infections, Cholesterol, Drug of Abuse, Coagulation, FOB, Pregnancy & Fertility, Other), 2022
  • At-Home IVD Tests Market by Sample Type
    • Table 3-4: Global At-Home IVD Market by Sample Type (Blood, Nasal, Oral/Saliva, Stool, Urine, Other), 2022 ($BN)
    • Figure 3-2: Global At-Home IVD Market by Distribution of Sales by Sample Type (Blood, Urine, Oral/Saliva, Nasal, Stool, Other), 2019 and 2022
    • Figure 3-3: Year-over-Year Growth for At-Home IVD Markets (Cholesterol, Coagulation, COVID-19, Drugs of Abuse, FOB, Glucose, HIV, Other Infections, Pregnancy & Fertility, Other), 2020-2021 and 2021-2022 (%)
  • Blood Samples
    • Figure 3-4: Estimated Distribution of Blood Sample Sales by Test Type (Cholesterol, Coagulation, Glucose, Other), 2022 (%)
  • Urine Samples
    • Figure 3-5: Estimated Distribution of Urine Sample Sales, by Test Type (Drug of Abuse, Infectious Disease, Pregnancy, Other), 2022 (%)
  • Oral/Saliva Samples
    • Figure 3-6: Estimated Distribution of Oral/Saliva Sample Sales by Test Type (COVID-19, Drug of Abuse, HIV, Other), 2022 (%)
  • Nasal Samples
    • Figure 3-7: Estimated Distribution of Nasal Sample Sales by Test Type (COVID-19, Other), 2022 (%)
  • Stool Samples
    • Figure 3-8: Estimated Distribution of Stool Sample Sales by Test Type (FOB, Other), 2022 (%)
  • Other

Chapter 4: Home Collection IVD Tests

  • Introduction
  • Pregnancy and Fertility
  • Infectious Disease
  • HIV
  • HPV and other STDs
  • COVID-19
  • COVID-19 & Flu
    • Table 4-1: Selected Molecular EUA Tests for COVID-19
  • Fecal Occult Blood
  • Cholesterol
  • Genetics
  • Home Collection IVD Tests by Test Type
    • Table 4-2: Global Home Collection IVD Market by Test Type (Genetics, Infectious Disease, Other Areas), 2022 ($BN)
    • Figure 4-1: Global Home IVD Market by Distribution of Sales by Segment (Cholesterol, Coagulation, COVID-19, Drug of Abuse, Genetic, HbA1c, HIV, Other Infections, Pregnancy & Fertility, Other), 2022 (%)
  • Privacy
  • Home Collection Tests by Sample Type
    • Table 4-3: Global Home Collection IVD Market by Sample Type (Blood, Nasal, Oral/Saliva, Stool, Urine, Other), 2022 ($BN)
    • Figure 4-2: Global Home Collection IVD Market by Distribution of Sales by Sample Type (Blood, Urine, Oral/Saliva, Nasal, Stool, Other), 2019 and 2022
    • Figure 4-3: Year-over-Year Growth for Home Collection IVD Markets, by Type (Cholesterol, Coagulation, COVID-19, Drug of Abuse, FOB, Genetic, HbA1c, HIV, Other Infections, Pregnancy & Fertility, Other), 2020-2021 and 2021-2022 (%)
  • Blood Samples
    • Figure 4-4: Estimated Distribution of Blood Sample Sales by Test Type (Cholesterol, Fertility, Genetic, Glucose/HbA1c, Infectious Disease - STD blood spot, Tumor Market - PSA blood spot, Other - hormone), 2022 (%)
  • Urine Samples
    • Figure 4-5: Estimated Distribution of Urine Sample Sales by Test Type (Infectious Disease - STD, Pregnancy/Fertility, Other - Heavy metals, hormone, nutrition), 2022 (%)
  • Oral/Saliva Samples
    • Figure 4-6: Estimated Distribution of Oral/Saliva Sample Sales by Test Type (COVID-19, Drug of Abuse, Fertility, Genetic, HIV, Other - hormone, nutrition, medication match), 2022 (%)
  • Nasal Samples
    • Figure 4-7: Estimated Distribution of Nasal Sample Sales by Test Type (COVID-19, Other), 2022 (%)
  • Stool Samples
    • Figure 4-8: Estimated Distribution of Stool Sample Sales by Test Type (FOB, Infectious Disease - pathogen ID, Other - Heavy metals), 2022 (%)
  • Other

Chapter 5: Market Participants

  • 23andMe, Inc.
    • Table 5-1: 23andMe Corporate Summary
    • Company Overview
      • Table 5-2: 23andMe Genetic Tests with FDA Marketing Authorization
    • Performance Review
      • Table 5-3: 23andMe Revenue, 2020-2022 ($ millions)
  • Abbott Diagnostics
    • Table 5-4: Corporate Summary
    • Company Overview
    • Performance Review
      • Table 5-5: Abbott Revenues, 2020-2022 (in millions $)
  • AccessBio, Inc.
    • Table 5-6: AccessBio Corporate Summary
    • Company Overview
    • ACON Laboratories, Inc.
      • Table 5-7: ACON Laboratories Corporate Summary
    • Company Overview
  • ARKRAY, Inc.
    • Table 5-8: ARKRAY Corporate Summary
    • Company Overview
  • Ascensia Diabetes Care Holdings AG
    • Table 5-9: Ascensia Diabetes Care Corporate Summary
    • Company Overview
  • Atomo Diagnostics
    • Table 5-10: Atomo Corporate Summary
    • Company Overview
    • Performance Review
      • Table 5-11: Atomo Revenues, 2021-2022 (in millions $)
  • Becton-Dickinson
    • Table 5-12: Becton-Dickinson Corporate Summary
    • Company Overview
    • Performance Review
      • Table 5-13: BD Corporation Revenue, 2020-2022 ($ millions)
  • binx health
    • Table 5-14: binx health Corporate Summary
    • Company Overview
  • Biomerica, Inc.
    • Table 5-15: Biomerica Corporate Summary
    • Company Overview
    • Company Financials
      • Table 5-16: Biomerica Corporation Revenue, 2020-2022 ($ millions)
  • Biosynex SA
    • Table 5-17: Biosynex Corporate Summary
    • Company Overview
    • Performance Review
      • Table 5-18: Biosynex Revenues 2021-2022 (in millions $)
  • BTNX Inc.
    • Table 5-19: BTNX Corporate Summary
    • Company Overview
  • Church & Dwight Co. Inc.
    • Table 5-20: Church & Dwight Corporate Summary
    • Company Overview
    • Performance Review
      • Table 5-21: Church and Dwight Revenues, 2020-2022 ($ millions)
  • Color Health, Inc.
    • Table 5-22: Color Health Corporate Summary
    • Company Overview
  • Cue Health
    • Table 5-23: Cue Health Corporate Summary
    • Company Overview
  • Dexcom, Inc.
    • Table 5-24: Dexcom Corporation Corporate Summary
    • Company Overview
    • Performance Review
      • Table 5-25: Dexcom Revenues, 2020-2022 ($ millions)
  • EasyDNA
    • Table 5-26: EasyDNA Corporate Summary
    • Company Overview
  • Everlywell
    • Table 5-27: Everlywell Corporate Summary
    • Company Overview
  • Exact Sciences
    • Table 5-28: Exact Sciences Corporate Summary
    • Company Overview
    • Performance Review
      • Table 5-29: Exact Sciences Revenues, 2020-2022 ($ millions)
  • First Check Diagnostics LLC
    • Table 5-30: First Check Diagnostics Corporate Summary
    • Company Overview
  • GlysBy diagnostics
    • Table 5-31: GlysBy Corporate Summary
    • Company Overview
  • Helena Laboratories
    • Table 5-32: Helena Laboratories Corporate Summary
    • Company Overview
  • Hemosure, Inc.
    • Table 5-33: Hemosure Corporate Summary
    • Company Overview
  • LifeScan, Inc.
    • Table 5-34: LifeScan Corporate Summary
    • Company Overview
  • Medichecks.com Ltd.
    • Table 5-35: Medichecks Corporate Summary
    • Company Overview
  • Myriad Genetics, Inc.
    • Table 5-36: Myriad Genetics Corporate Summary
    • Company Overview
    • Performance Review
      • Table 5-37: Myriad Diagnostics Revenue, 2020-2022 ($ millions)
  • OraSure Technologies, Inc.
    • Table 5-38: OraSure Technologies Summary
    • Company Overview
    • Performance Review
      • Table 5-39: OraSure Revenues, 2020-2022 ($ millions)
  • Polymedco, Inc.
    • Table 5-40: Polymedco Corporate Summary
    • Company Overview
  • Preventis GmbH
    • Table 5-41: Preventis Corporate Summary
    • Company Overview
  • Prima Lab SA
    • Table 5-42: Prima Corporate Summary
    • Company Overview
  • QuidelOrtho Corporation
    • Table 5-43: QuidelOrtho Corporate Summary
    • Company Overview
    • Performance Review
      • Table 5-44: QuidelOrtho Revenues, 2020-2022 ($ millions)
  • Roche Diagnostic Corporation
    • Table 5-45: Roche Diagnostic Corporate Summary
    • Company Overview
    • Performance Review
      • Table 5-46: Roche Diagnostics, 2020-2022 ($ millions)
  • Siemens Healthineers GmbH
    • Table 5-47: Siemens Healthineers Corporate Summary
    • Company Overview
    • Performance Review
      • Table 5-48: Siemens Healthineers, 2020-2022 ($ millions)
  • Swiss Precision Diagnostics GmbH
    • Table 5-49: Swiss Precision Diagnostics Corporate Summary
    • Company Overview
  • Trividia Health
    • Table 5-50: Trividia Health Corporate Summary
    • Company Overview
  • VedaLab
    • Table 5-51: VedaLab Corporate Summary
    • Company Overview

Chapter 6: Market Analysis

  • Market Overview
    • Figure 6-1: Global Home IVD Market, 2022-2027, 5% CAGR, ($MN)
  • Market Segment by Test Type
    • Figure 6-2: Global Home IVD Market by Test Type (Genetic, Glucose/HbA1c, Infectious Disease, Other Areas), 2019-2022 ($MN)
    • Figure 6-3: Global Home IVD Market, by General Test Segment (Genetic, Glucose/HbA1c, Infectious Disease, Other Areas), 2022
  • Glucose & HbA1c
    • Table 6-1: Estimated Global Home IVD Glucose & HbA1c Testing Market, 2022-2027 $MN; CAGR 22-27
  • Infectious Disease
    • Table 6-2: Estimated Global Home IVD Infectious Disease Testing Market, 2022-2027 $MN; CAGR 22-27
  • Other Areas
    • Table 6-3: Estimated Global Home IVD Other Testing Market, 2022-2027 $MN; CAGR 22-27
  • Genetic
    • Table 6-4: Estimated Global Home IVD Genetic Testing Market, 2022-2027 $MN; CAGR 22-27
  • Market by Distribution
  • Market by Region
    • Figure 6-4: Estimated Global Home IVD Testing Market, by Region (APAC, EMEA, United States, Rest of World), 2019-2022
  • Competitive Analysis
    • Figure 6-5: Estimated Global Home IVD Testing Market, Vendor Market Share, by Top Five Market Vendors (Abbott, Dexcom, QuidelOrtho, Roche, Siemens Healthineers, Other), 2022